✦ LIBER ✦

The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells

✍ Scribed by Artur Slupianek; Smitha Yerrum; Fayez F. Safadi; M. Alexandra Monroy

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 227 KB
Volume: 224
Category: Article
ISSN: 0021-9541
DOI: 10.1002/jcp.22132

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The SNF2‐related CBP activator protein (SRCAP) serves as a coactivator for several nuclear receptors including the androgen receptor (AR). SRCAP is an ATPase that is the core subunit of a large multiprotein complex and was shown to incorporate the histone variant H2A.Z into nucleosomes. In this report, we demonstrate that SRCAP is expressed in the epithelium of normal prostate and in prostate carcinoma cells, and is associated with AR in the nucleus. Using transient transfection assays we demonstrate that SRCAP activates hormone‐dependent transcription of the androgen responsive, prostate specific antigen (PSA)‐Luciferase reporter gene in human prostate cells. The in vivo occupancy of SRCAP at the endogenous PSA promoter is demonstrated using chromatin immunoprecipitation assays. ShRNA mediated knockdown of SRCAP resulted in decreased H2A.Z binding at the enhancer region of the PSA promoter and decreased expression of PSA in prostate cancer cells. Furthermore, inhibition of SRCAP expression significantly inhibited androgen dependent prostate cancer cell growth. These data identify SRCAP as a physiologically relevant mediator of PSA expression, and demonstrate that SRCAP plays a role in prostate cancer cell proliferation. J. Cell. Physiol. 224: 369–375, 2010. © 2010 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Expression of prostate-specific antigen

Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells

✍ Joanne N. Davis; Omer Kucuk; Fazlul H. Sarkar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

Prostate cancer is the second-leading cause of cancer-related deaths in men in the United States. Unfortunately, there is no effective therapy when prostate cancer becomes metastatic and refractory to conventional treatments. For this reason, the identification and exploration of new agents that red

Correlation of the osteoblastic phenotyp

Correlation of the osteoblastic phenotype with prostate-specific antigen expression in metastatic prostate cancer: implications for paracrine growth

✍ Doherty, Alan; Smith, Gillian; Banks, Linda; Christmas, Timothy; Epstein, Richar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

The characteristic sclerotic appearance of bone metastases from prostate cancer is unexplained but could involve excess peritumoural activity of osteoblast mitogens such as the insulin-like growth factors (IGFs). Since prostatic metastases are distinguished by androgen-dependent secretion of prostat

Curcumin provides potential protection a

Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells

✍ Li-Chuan Chung; Ke-Hung Tsui; Tsui-Hsia Feng; Shiow-Ling Lee; Phei-Lang Chang; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

## Abstract **Scope:** Prostate‐specific antigen (PSA) is a well‐known marker for diagnosing and monitoring prostate cancer. Curcumin, a yellow curry pigment, has been reported to enhance androgen receptor (AR) degradation. We examined the effects of curcumin on increasing PSA expression by hypoxia

Targeted inhibition of the epidermal gro

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 (‘Iressa’) induces cell-cycle arrest and inhibits proliferation in prostate cancer cells

✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a

The prognostic significance of prolifera

The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma : A comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2

✍ Bhaskar V. S. Kallakury; Christine E. Sheehan; Sue J. Rhee; Hugh A. G. Fisher; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

In this study, the authors evaluated the prognostic significance of the expression of nucleolar antigen p120, along with other cell proliferationassociated proteins, in prostate adenocarcinomas (PACs) and compared the results with previously reported data on p34 cdc2 cyclin-dependent kinase (p34 cdk

A widely expressed transcription factor

A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers

✍ Galina N. Filippova; Annika Lindblom; Linda J. Meincke; Elena M. Klenova; Paul E 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

The cellular protooncogene MYC encodes a nuclear transcription factor that is involved in regulating important cellular functions, including cell cycle progression, differentiation, and apoptosis. Dysregulated MYC expression appears critical to the development of various types of malignancies, and t